Oral semaglutide is typically used at doses of 7 mg or 14 mg daily, which correspond to relatively low GLP-1 receptor activation compared to injectable doses
The study was approved by the Hospital Universitari Sant Joan de Reus and Fundaci Jordi Gol i Gorina Ethics Committees (PI Joan D Fernndez-Ballart, CEIC 30/06/1998
Surgery changes your body to help it make more GLP-1 Medication gives you a synthetic version to help boost levels And when that natural boost from surgery starts to fade, meds can step in and keep things going
GLP-1s are preferred because they have a lower risk of hypoglycemia and a greater potential for weight loss
EAC seems to have both an antioxidant and anti-inflammatory effect , and it's claimed to be able to boost the skin's collagen production
The program starts July 1, 2026, and is scheduled to end December 31, 2027